3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 3
1
Status
Completed
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Other
1
Conditions
Polycystic Ovary Syndrome
2
Weight Loss
1
Prediabetic State
1
Obesity, Abdominal
1
Glucose Intolerance
1
Cardiovascular Diseases
1
Interventions
Metformin
14
Clomiphene
6
Progesterone
5
Chorionic Gonadotropin
5
drospirenone and ethinyl estradiol combination
4
Sugars
4
Letrozole
4
Flutamide
4
Estrogens
4
Cholecalciferol
4
follitropin alfa
3
Pioglitazone
3
Medroxyprogesterone Acetate
3
Glycoprotein Hormones, alpha Subunit
3
Estradiol
3
Vitamin D
2
Testosterone
2
Resistance Training
2
Raloxifene Hydrochloride
2
Ovidrel
2
Liraglutide
2
Leuprolide
2
Glucose Tolerance Test
2
Exenatide
2
Ethinyl Estradiol
2
Contraceptives, Oral
2
Continuous Positive Airway Pressure
2
saxagliptin
1
salicylsalicylic acid
1
penclomedine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Has results
×
Polycystic Ovary Syndrome
×
Liraglutide
×
Clear all
NCT03480022
2021-06-07
SAXAPCOS
Woman's
Phase 3
Completed
88 enrolled
35 charts
NCT02073929
2019-02-28
LIPT
Herlev Hospital
Phase 4
Completed
72 enrolled
18 charts